| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc8c6d3897f76437eca66b9d9c64377e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7105207ca740add5aa1300e0c7f20a8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_840593066699af23c56425b9a28d43db |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2005-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_288dcf2ec2271fe0a4b5d4563fb00aa7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_598311579140042f404069a1cf918eda |
| publicationDate |
2006-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006043031-A2 |
| titleOfInvention |
Class iii slrp for the treatment of cancer |
| abstract |
There is provided the use of an agent that promotes class III SLRP activity in the manufacture of a medicament for the prevention and/or treatment of cancer. Such medicaments may be used in the treatment of tumours, including avascular tumours. Suitable agents to be used may preferably include the class III SLRPs opticin; epiphycan; or mimecan. The invention also provides a method for the prevention and/or treatment of cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011012268-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10234462-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7910567-B2 |
| priorityDate |
2004-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |